Annual Drug Patent Expirations for ALTRENO
Altreno is a drug marketed by Dow Pharm and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has five patent family members in five countries.
The generic ingredient in ALTRENO is tretinoin. One supplier is listed for this compound. Additional details are available on the tretinoin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
